128 related articles for article (PubMed ID: 31776466)
21. Speckle-type POZ protein, SPOP, is involved in the DNA damage response.
Zhang D; Wang H; Sun M; Yang J; Zhang W; Han S; Xu B
Carcinogenesis; 2014 Aug; 35(8):1691-7. PubMed ID: 24451148
[TBL] [Abstract][Full Text] [Related]
22. HOIL-1, an atypical E3 ligase that controls MyD88 signalling by forming ester bonds between ubiquitin and components of the Myddosome.
Cohen P; Kelsall IR; Nanda SK; Zhang J
Adv Biol Regul; 2020 Jan; 75():100666. PubMed ID: 31615747
[TBL] [Abstract][Full Text] [Related]
23. SPOP Mutations Target STING1 Signaling in Prostate Cancer and Create Therapeutic Vulnerabilities to PARP Inhibitor-Induced Growth Suppression.
Geng C; Zhang MC; Manyam GC; Vykoukal JV; Fahrmann JF; Peng S; Wu C; Park S; Kondraganti S; Wang D; Robinson BD; Loda M; Barbieri CE; Yap TA; Corn PG; Hanash S; Broom BM; Pilié PG; Thompson TC
Clin Cancer Res; 2023 Nov; 29(21):4464-4478. PubMed ID: 37581614
[TBL] [Abstract][Full Text] [Related]
24. SPOP promotes CREB5 ubiquitination to inhibit MET signaling in liver cancer.
Gong DA; Zhou P; Chang WY; Yang JY; Zhang YL; Huang AL; Tang N; Wang K
Biochim Biophys Acta Mol Cell Res; 2024 Feb; 1871(2):119642. PubMed ID: 37996058
[TBL] [Abstract][Full Text] [Related]
25. Quantification of mutant SPOP proteins in prostate cancer using mass spectrometry-based targeted proteomics.
Wang H; Barbieri CE; He J; Gao Y; Shi T; Wu C; Schepmoes AA; Fillmore TL; Chae SS; Huang D; Mosquera JM; Qian WJ; Smith RD; Srivastava S; Kagan J; Camp DG; Rodland KD; Rubin MA; Liu T
J Transl Med; 2017 Aug; 15(1):175. PubMed ID: 28810879
[TBL] [Abstract][Full Text] [Related]
26. Generation and Surgical Analysis of Genetic Mouse Models to Study NF-κB-Driven Pathogenesis of Diffuse Large B Cell Lymphoma.
Maybury BD; Saavedra-Torres Y; Snoeks TJA; Fitzgibbon J; Calado DP
Methods Mol Biol; 2021; 2366():321-342. PubMed ID: 34236648
[TBL] [Abstract][Full Text] [Related]
27. ELK3 destabilization by speckle-type POZ protein suppresses prostate cancer progression and docetaxel resistance.
Lee CJ; Lee H; Kim SR; Nam SB; Lee GE; Yang KE; Lee GJ; Chun SH; Kang HC; Lee JY; Lee HS; Cho SJ; Cho YY
Cell Death Dis; 2024 Apr; 15(4):274. PubMed ID: 38632244
[TBL] [Abstract][Full Text] [Related]
28. SYK is activated by mutated MYD88 and drives pro-survival signaling in MYD88 driven B-cell lymphomas.
Munshi M; Liu X; Chen JG; Xu L; Tsakmaklis N; Demos MG; Kofides A; Guerrera ML; Jimenez C; Chan GG; Hunter ZR; Palomba ML; Argyropoulos KV; Meid K; Keezer A; Gustine J; Dubeau T; Castillo JJ; Patterson CJ; Wang J; Buhrlage SJ; Gray NS; Treon SP; Yang G
Blood Cancer J; 2020 Jan; 10(1):12. PubMed ID: 32005797
[TBL] [Abstract][Full Text] [Related]
29. WWP2 binds to NKRF, enhances the NF-κB signaling, and promotes malignant phenotypes of acute myeloid leukemia cells.
Wang H; Lian X; Wang K; Wang S
Biochem Cell Biol; 2024 Feb; 102(1):85-95. PubMed ID: 37921219
[TBL] [Abstract][Full Text] [Related]
30. ABLIM1, a novel ubiquitin E3 ligase, promotes growth and metastasis of colorectal cancer through targeting IĸBα ubiquitination and activating NF-ĸB signaling.
He Y; Shi Q; Ling Y; Guo H; Fei Y; Wu R; Tang C; Zhang X; Yao L
Cell Death Differ; 2024 Feb; 31(2):203-216. PubMed ID: 38228802
[TBL] [Abstract][Full Text] [Related]
31. Hidden tricks in MATH: Hypermorphic mutations in SPOP tumor suppressor explained by cryo-EM.
Orme JJ; Mer G; Huang H
Mol Cell; 2023 Mar; 83(5):655-656. PubMed ID: 36868187
[TBL] [Abstract][Full Text] [Related]
32. Substrate-dependent interaction of SPOP and RACK1 aggravates cardiac fibrosis following myocardial infarction.
Yang W; Zhuang Y; Wu H; Su S; Li Y; Wang C; Tian Z; Peng L; Zhang X; Liu J; Pei X; Yuan W; Hu X; Meng B; Li D; Zhang Y; Shan H; Pan Z; Lu Y
Cell Chem Biol; 2023 Oct; 30(10):1248-1260.e4. PubMed ID: 37442135
[TBL] [Abstract][Full Text] [Related]
33. Regulation of NF-κB by ubiquitination.
Chen J; Chen ZJ
Curr Opin Immunol; 2013 Feb; 25(1):4-12. PubMed ID: 23312890
[TBL] [Abstract][Full Text] [Related]
34. G3BP1 modulates SPOP to promote prostate tumorigenesis.
Mukhopadhyay C; Zhou P
Mol Cell Oncol; 2022; 9(1):2030171. PubMed ID: 35252555
[TBL] [Abstract][Full Text] [Related]
35. LRP5 competes for SPOP binding to enhance tumorigenesis mediated by Daxx and PD-L1 in prostate cancer.
Gan S; Qu F; Zhang X; Pan X; Xu D; Cui X; Hou J
Exp Cell Res; 2024 Jan; 434(1):113857. PubMed ID: 38008278
[TBL] [Abstract][Full Text] [Related]
36. HS3ST1 Promotes Non-Small-Cell Lung Cancer Progression by Targeting the SPOP/FADD/NF-
Ji X; Cheng K; Gao C; Xie H; Zhu R; Luo J
Biomed Res Int; 2022; 2022():5509346. PubMed ID: 35909476
[TBL] [Abstract][Full Text] [Related]
37. Reduction of oligomer size modulates the competition between cluster formation and phase separation of the tumor suppressor SPOP.
Sabri N; Cuneo MJ; Marzahn MR; Lee J; Bouchard JJ; Vaithiyalingam S; Borgia MB; Schmit J; Mittag T
bioRxiv; 2023 Mar; ():. PubMed ID: 36993550
[TBL] [Abstract][Full Text] [Related]
38. Cbl-b negatively regulates TLR/MyD88-mediated anti-
Wei H; Wu S; Mai L; Yang L; Zou W; Peng H
Microbiol Spectr; 2023 Dec; 11(6):e0007423. PubMed ID: 37909781
[TBL] [Abstract][Full Text] [Related]
39. The IRAK-M death domain: a tale of three surfaces.
Gürkan B; Poelman H; Pereverzeva L; Kruijswijk D; de Vos AF; Groenen AG; Nollet EE; Wichapong K; Lutgens E; van der Poll T; Du J; Wiersinga WJ; Nicolaes GAF; van 't Veer C
Front Mol Biosci; 2023; 10():1265455. PubMed ID: 38268724
[TBL] [Abstract][Full Text] [Related]
40. Targeting selective E3 ligase for healing cardiac fibrosis.
Yang G
Cell Chem Biol; 2023 Oct; 30(10):1188-1190. PubMed ID: 37863032
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
